Register for SOSV HAX Investor Showcase – April 1, 2026

Portfolio Companies

Reset All Filters                
Key Trends
Programs
Stage
Category
Region
Location

Afynia

Globally, one in ten women will suffer from endometriosis, a painful and debilitating gynecological condition. On average, women don’t get a proper diagnosis for five to twelve years after the onset of symptoms because, until now, the only reliable way to do so was via laparoscopic surgery that can cost over $20,000 and require three […]

Locations: Canada

Level Zero Health

Level Zero Health is a biotech startup pioneering Continuous Hormone Monitoring. Utilising DNA-based sensing technology their devices provide real-time insights into hormonal health, empowering individuals and clinicians to make informed decisions. Starting with IVF and Testosterone Deficiency, they are transforming how hormonal data is accessed and used.

Locations: United Kingdom

Samphire Neuroscience

Samphire Neuroscience builds neurotechnology for neglected areas of women’s chronic health. Their first product, Nettle, is a medically-certified brain stimulating wearable that reduces pain and improves PMS symptoms for women of reproductive age, including patients with endometriosis, severe PMS (PMDD), uterine fibroids and beyond. Samphire has demonstrated initial commercial PMF validation following their clinical trials […]

Locations: United States

AIMA

Period pain has an immediate negative impact on the quality of life, forcing 41% of menstruators to miss work or school. For places like the US, this results in over $7B loss annually. Current treatment options such as painkillers (NSAIDs), hormones, opioids, and surgery have serious side effects like kidney failure, stomach ulcers, blood clots, strokes, […]

Locations: Canada
AJA Labs

Aja Labs

Around the developing world, women and girls as young as eight years old are paid just $11 to $25 for selling their hair to supply the hair extension marketplace. The only readily available alternative is plastic synthetic hair, made from petrochemicals, from which consumers often experience toxicity reactions. At worst, these plastics potentially trigger endocrine […]

Locations: United States

Aksense

Aksense is providing a rapid test with a portable electrochemical biosensor to diagnose infections.

Locations: United Kingdom

AMMA Pregnancy Tracker

Pregnancy Tracker is a one-stop mobile application to improve mental and physical health families worldwide.

BioAesthetics

BioAesthetics

BioAesthetics’ Nipple-Areolar Complex Graft, or NACgraft, is a revolutionary next step in breast reconstruction that will provide patients who have had mastectomies with a new, natural, living nipple and areola. The NACgraft is a cell-free, biologically-derived nipple and areola graft that once applied by a surgeon, will allow the patient’s own body to integrate the […]

Locations: United States

BryoSphere Biotechnologies

Why we invested: Our investment in BryoSphere is an addition to SOSV’s next-gen biomanufacturing portfolio that spans a diversity of chassis, processes, vessels, and feedstocks. BryoSphere is one of the only companies in the world to use moss cells in photobioreactors as an expression system. These ancient plants are really good at making compounds to […]

Locations: Canada

No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the “Materials”), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.